ICD-10 Coding for Vaginal Atrophy(N89.8, N89.8B, N89.8O)
Explore the ICD-10 coding for vaginal atrophy, including postmenopausal atrophic vaginitis (N95.2). Learn about documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Vaginal Atrophy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N95.2 | Postmenopausal atrophic vaginitis | Use when the patient is postmenopausal and presents with symptoms of vaginal atrophy. |
|
| N89.8 | Other noninflammatory disorders of vagina | Use for vaginal atrophy not related to menopause. |
|
| N90.5 | Atrophy of vulva | Use when vulvar atrophy is present alongside vaginal atrophy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutVaginal Atrophy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Vaginal Atrophy.
Failing to document menopausal status
Impact
Clinical: Misdiagnosis risk., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Always confirm and document menopause in relevant cases.
Using N95.2 without confirming menopause
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Mitigation
Ensure menopause is documented before using N95.2.
Menopausal status documentation
Impact
Lack of documentation can lead to audit issues.
Mitigation
Ensure all patient records include menopausal status when coding N95.2.